
USA - NASDAQ:MGEN -
ChartMill assigns a Buy % Consensus number of 90% to MGEN. The Buy consensus is the weighted average rating of the current analysts ratings.
The consensus rating for Miragen Therapeutics Inc (MGEN) is 90 / 100 . This indicates that analysts generally have a positive outlook on the stock.
The number of analysts covering Miragen Therapeutics Inc (MGEN) is 4.